Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Liang Huang"'
Autor:
Lu Sun, Xiaoliang Jin, Liang Huang, Jing Zhao, Haifeng Jin, Mingtao Chen, Chunli Zhang, Bin Lu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundChronic atrophic gastritis (CAG) can progress to gastric cancer (GC) thus requiring endoscopic surveillance. Here, we analyze various aspects of CAG progression, time, and mucosal background, to guide reasonable surveillance.MethodsCAG pati
Externí odkaz:
https://doaj.org/article/a337d2b07e58404fbe127e14e476017b
Autor:
Wanying Liu, Chunrui Li, Yang Cao, Na Wang, Liang Huang, Zhen Shang, Jue Wang, Lifang Huang, Jinhuan Xu, Min Xiao, Yicheng Zhang, Jianfeng Zhou, Liting Chen, Yi Xiao
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIntravascular large B-cell lymphoma (IVLBCL) is a rare, aggressive, large B-cell non-Hodgkin’s lymphoma. The prognosis of IVLBCL in patients with central nervous system recurrence after first-line chemotherapy treatment is extremely poor.
Externí odkaz:
https://doaj.org/article/7119b692f2b544ada900e2c69df39d09
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background and AimEndoscopic submucosal excavation (ESE) is commonly used to treat gastrointestinal stromal tumors (GISTs), especially for tumor sizes within 2 cm; compared with the conventical ESE, the efficacy and safety of the no-submucosal inject
Externí odkaz:
https://doaj.org/article/dd503d68009e4c0985bbf8c5d5f0fa01
Autor:
Xiaolin Pang, Liang Huang, Yan Ma, Zhanzhen Liu, Peiyi Xie, Hailing Liu, Xiangbo Wan, Shuai Liu, Jian Zheng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPatients with lateral lymph nodes (LLNs) metastasis are not effectively treated with neoadjuvant chemoradiotherapy. This study aimed to compare the efficacy of three neoadjuvant therapeutic regimens, namely, chemotherapy, chemoradiotherapy,
Externí odkaz:
https://doaj.org/article/56ebf7e79ec3474489e3999db5409f47
Autor:
Liang Huang, Shuanglin Luo, Xingwei Zhang, Yonghua Cai, Fangqin Xue, Huanxin Hu, Ziwei Zeng, Tengjiao Lin, Fei Wang, Weifeng Wang, Sen Zhang, Liang Kang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Colorectal mucinous carcinoma (MC) is associated with inferior prognosis and response to treatment compared to adenocarcinoma (AC). The molecular landscapes of MC and adenocarcinoma with mucous composition (AMC) are not well-defined. We aimed to desc
Externí odkaz:
https://doaj.org/article/4327052b9e934f49aee9edc0e69ea8a8
Autor:
Yuqi Guan, Meilan Zhang, Wei Zhang, Jiachen Wang, Kefeng Shen, Kai Zhang, Li Yang, Liang Huang, Na Wang, Min Xiao, Jianfeng Zhou
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) accounts for 20–30% of adult patients with ALL, characterized by translocation of t(9, 22). Tyrosine kinase inhibitors (TKIs) have significantly improved the outcome even tho
Externí odkaz:
https://doaj.org/article/0469aba05b3540ddabe9426b7c75e2b3
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundLittle is known regarding the clinicopathologic characteristics, oncologic outcomes, and treatment strategies that could be ascribed to BRCA mutation in early-onset triple-negative breast cancer (eTNBC).MethodseTNBC patients who underwent B
Externí odkaz:
https://doaj.org/article/78bbedc12e9c465b9507210bc82055ea
Autor:
Tongjuan Li, Lei Zhao, Yuanyuan Zhang, Yi Xiao, Di Wang, Liang Huang, Liya Ma, Liting Chen, Songya Liu, Xiaolu Long, Fankai Meng, Xiaojian Zhu, Jia Wei, Bin Xu, Jianfeng Zhou, Xiaoxi Zhou
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Advanced central nervous system (CNS) lymphoma is an exclusion criterion for most chimeric antigen receptor (CAR) T-cell studies due to the associated levels of neurotoxicity. In this study, we described five patients with chemorefractory B-cell CNS
Externí odkaz:
https://doaj.org/article/b6f9c7191cdf46deb98798310a5a9e54
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Goals: BRCA1/2 mutations are associated with bilateral breast cancer. The extent of concordance between synchronous bilateral breast cancer (SBBC) tumors with respect to hormone receptor expression and BRCA1/2 mutations is unknown. We investigated th
Externí odkaz:
https://doaj.org/article/ca7e37ae32f8463ab0111d7be589684e
Autor:
Fa-Sheng Liu, Hua-Liang Huang
Publikováno v:
Frontiers in Oncology; 2024, p01-05, 5p